LAVA Therapeutics N.V. earnings per share and revenue

LVTX earnings per share for the last quarter are -0.46 USD whereas the estimation was -0.33 USD which accounts for -39.39% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.29 USD, and revenue is expected to reach 2.50 M USD. Also watch annual changes over time to get a bigger picture of LVTX earnings per share and revenue dynamics.